Sanofi India Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on 29th April 2026.
SANOFI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sanofi India Limited held its 70th AGM on 29th April 2026 via video conferencing with 72 members attending. The meeting approved adoption of FY 2025 financial statements, confirmed interim dividend of Rs. 75 per share, and declared a final dividend of Rs. 48 per share for FY 2025. Key board changes include Chairman Aditya Narayan concluding his tenure and handing over to Rahul Bhatnagar from 30th April 2026, while Independent Director Usha Thorat also completed her tenure. The company appointed Sudipta Chakraborty as Whole-time Director, and Rajani Kesari and Siraj Azmat Chaudhry as Independent Directors for 5-year terms. The meeting also approved material related party transactions with Sanofi-Aventis Singapore Pte. Limited and Sanofi Healthcare India Private Limited.
Dividend confirmation signals stable cash flows and shareholder returns. Multiple board transitions including new chairman and director appointments may bring strategic shifts. Related party transaction approvals indicate continued关联交易 with Sanofi group entities.